Lonza Group (LONN) 43rd Annual J.P. Morgan Healthcare Conference 2025 summary

Key strategic vision and initiatives

• Introduced a unified vision to become a pure-play CDMO, leveraging the Lonza Engine and aiming for industry leadership through cutting-edge science, technology, and lean manufacturing.

• CEO outlined a multi-step plan: establish unified vision and culture, assemble the Lonza Engine, and tune operations via focus, reshaping, elevating execution, and expansion.

• Shift to a simplified operating model with three integrated business platforms, removing a management layer for faster decisions, to be implemented in Q2 2024/2025.

• Decision to exit the Capsules and Health Ingredients (CHI) business to focus on core CDMO activities, with timing based on maximizing value and limited synergies.

• The Lonza Engine comprises team strength, scientific ecosystem, customer partnerships, execution excellence, and scalable investment capabilities.

Market outlook and growth plans

• CDMO/biopharma market expected to grow 8-10% annually, with Lonza targeting low-teens organic growth, 2-3% ahead of the market.

• Growth driven by organic expansion and selective M&A, focusing on high-growth modalities like cell and gene therapy, ADCs, and biologics.

• CapEx to remain mid- to high-teens % of sales, supporting infrastructure, capacity, and new technologies.

• 2025 outlook: CDMO sales growth approaching 20% (including CHF 500m from Vacaville acquisition), Core EBITDA margin nearing 30%.

• Strategic priorities include expanding in capacity-constrained markets, diversifying advanced synthesis, and extending specialized modalities.

Execution, integration, and risk management

• 22 global growth projects underway, including integration of the Vacaville site, with a focus on on-time and on-budget delivery.

• CapEx program for Vacaville (CHF 500m) to enhance flexibility and add technologies over 3-4 years, with careful planning to avoid operational disruption.

• Ongoing focus on harmonizing systems, leveraging plug-and-play integration, and maintaining a strong global footprint, especially in Western markets.

• Management confident in supply-demand balance, seeing more demand than supply in key modalities, reducing risk of overcapacity.

• Emphasis on disciplined investments, operational excellence, and leveraging the Lonza Engine for sustained value creation.